Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Patent opposition analysis in Peptide Synthesis industry

In the competitive field of Peptide Synthesis, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Peptide Synthesis technology and learn how to protect your intellectual property.

Get Comprehensive Patent Opposition Report for the Peptide Synthesis Industry

Gain strategic insights, uncover critical details, and make informed decisions with expert-backed analysis.

Get Your Report Now

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions
STRAWMAN73
JAMES POOLE44
MAIWALD37
REGENERON PHARMACEUTICALS34
HOFFMANN EITLE30
MARGARET DIXON24
PFIZER22
KONIG SZYNKA TILMANN VON RENESSE21
BOULT WADE TENNANT20
SANOFI19

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

CompanyTotal Oppositions
GENENTECH81
F HOFFMANN LA ROCHE72
AMGEN55
CHUGAI SEIYAKU KABUSHIKI KAISHA52
REGENERON PHARMACEUTICALS50
FHOFFMANN LA ROCHE45
NOVARTIS42
BRISTOL MYERS SQUIBB36
SANOFI BIOTECHNOLOGY30
AMGEN RESEARCH MUNICH27

Top active law firms filing patent oppositions New

Explore the top law firms that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions Filed
CARPMAELS & RANSFORD75
HOFFMANN EITLE72
MAIWALD64
MEWBURN ELLIS47
J A KEMP45
D YOUNG33
KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF32
DORRIES30
BOULT WADE TENNANT29
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB24

Latest patents opposed in the Peptide Synthesis industry

Patent challenges are becoming increasingly common in the Peptide Synthesis industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Peptide Synthesis industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Peptide Synthesis industry

EP3490582Methods And Compositions For Treating MyelofibrosisACCELERON PHARMAMar 12, 2025MAIWALD
EP3507369Anti-Cd20 AntibodyBEIJING MABWORKS BIOTECHMar 12, 2025ARROWHOUSE
EP3507369Anti-Cd20 AntibodyBEIJING MABWORKS BIOTECHMar 11, 2025KARO
EP3490582Methods And Compositions For Treating MyelofibrosisACCELERON PHARMAMar 10, 2025WUESTHOFF & WUESTHOFF PATENTANWALTE UND RECHTSANWALT PARTG MBB
EP3202785Method For The Production Of A Glycosylated ImmunoglobulinF HOFFMANN LA ROCHEFeb 10, 2025STRAWMAN
EP3237004Predicting Outcome Of Treatment With An Anti- 4 7 Integrin AntibodyMILLENNIUM PHARMACEUTICALSFeb 7, 2025POLPHARMA BIOLOGICS
EP3167888Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementALEXION PHARMACEUTICALSJan 31, 2025SALUTE HC ILAC PAZARLAMA
EP3270966Combination Of Hdac Inhibitor And Anti-Pd-1 Antibody For Treatment Of CancerSYNDAX PHARMACEUTICALSJan 31, 2025MAIWALD
EP3515475Chimeric Antigen Receptor (Car) That Targets Chemokine Receptor Ccr4 And Its UseTHE UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRSJan 30, 2025WEICKMANN & WEICKMANN PARTMBB
EP3411476Enhanced Production Of ImmunoglobulinsTRIANNIJan 24, 2025REGENERON PHARMACEUTICALS

Top patents facing oppositions in Peptide Synthesis industry

To stay ahead in the competitive Peptide Synthesis industry, companies are constantly innovating. Here are the top patents facing oppositions in the Peptide Synthesis industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2188302Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH11
EP2462158Jan 10, 2018Method To Improve Virus Removal In Protein PurificationGENENTECH11
EP2825558May 15, 2019Combination Therapy For The Treatment Of Ovarian CancerF HOFFMANN LA ROCHE10
EP2971040Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
EP3177645Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLUDWIG MAXIMILIANS UNIVERSITT MNCHEN10
EP2791160Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA THERAPEUTICS10
EP3616720Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentSHIONOGI10
EP2586788Nov 29, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH9
EP2766040May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHE9
EP3322731Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB9